|
Carlo M. Croce is an Italian medical doctor, specializing in oncology and noted for research into the genetic mechanisms of cancer. Croce is one of the most highly recognized and awarded Italian researchers in the world, and is currently involved in the study of microRNAs and their role in oncology. Croce has received numerous awards, including the 2006 Clowes Memorial Award from the American Association for Cancer Research for his discoveries of the molecular mechanisms of Leukemia. In 2010, he was elected a fellow of the American Academy of Arts and Sciences.〔(American Academy of Arts and Sciences (Members): Carlo M. Croce )〕 Based on his merit in the field of science, he was awarded the honour of ''Cavaliere di Gran Croce'' by the President of Italy, Carlo Azeglio Ciampi and is ranked first on the Italian Academy's list of the 715 Italian scientists having the most impact on medical research around the world. He is now Director of Human Cancer Genetics, Chairman of Molecular Virology, Immunology and Medical Genetics, and Director of the Institute of Genetics at The Ohio State University Comprehensive Cancer Center. He is also Professor of Medical Oncology at the University of Ferrara School of Medicine. ==Education and career== Croce was born on December 17, 1944 in Milan, Italy to a housewife and a mechanical engineer. At age 2, he moved to Rome with his family. In 1963 he entered the school of medicine of La Sapienza University of Rome and graduated in 1969 with "summa cum laude" in medicine and Latin. He began his career in the United States the following year as an associate scientist at the Wistar Institute of Biology and Anatomy in Philadelphia. In 1980, he was named Wistar Professor of Genetics at the University of Pennsylvania and associate director of the Wistar Institute, titles he held until 1988. From 1988-91, he was director of the Fels Institute for Cancer Research and Molecular Biology at Temple University School of Medicine in Philadelphia. In 1991, Dr. Croce was named Director of the Kimmel Cancer Center at Jefferson Medical College at the Thomas Jefferson University in Philadelphia. While at Jefferson, he discovered the role of microRNAs in cancer pathogenesis and progression, implicating a new class of genes in cancer causation. In 2004 he moved to Ohio State University, where under his direction the faculty within the Human Cancer Genetics Program conduct both clinical and basic research. Basic research projects focus on how genes are activated and inactivated, how cell-growth signals are transmitted and regulated within cells, and how cells interact with the immune system. Clinical research focuses on discovering genes linked to cancer and mutations that predispose people to cancer. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Carlo M. Croce」の詳細全文を読む スポンサード リンク
|